CHGA and small cell lung carcinoma: Detailed patient demographics and quantitative analysis of neuroendocrine biomarker expression (KI-67, Chromogranin A, Synaptophysin, CD56, TTF1, ASCL1, and DLL3) in small cell lung cancer (SCLC) cohort